MV-NIS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MV-NIS, covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer [Phase 2]